Novo’s Wegovy gets EMA nod to treat heart failure in obese people
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.
Drugs
Health
Pharma
Drugs
Health
Pharma
UN report calls for global governance of artificial intelligence
The imperative for the global governance of artificial intelligence (AI) is “irrefutable” as its accelerating development concentrates power and wealth on a global.
Drugs
Health
Pharma
FDA faces Vanda’s ire as it rejects firm’s gastroparesis drug application
Vanda Pharmaceuticals Inc’s gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for.
Drugs
Health
Pharma
Bleeding disorder trial halted after pomalidomide drug proves efficacy
Researchers supported by the National Institutes of Health stopped a trial after they gathered sufficient evidence that an experimental drug to treat a.
Drugs
Health
Pharma
Basilea in $268m pact with BRDA for antifungals, antibacterials
The US-based Biomedical Advanced Research and Development Authority will help Switzerland’s Basilea Pharmaceutica Ltd., to develop antifungals and antibacterials with an initial funding.
Drugs
Health
Pharma
Merck’s advanced lung cancer drug gets US drug regulator’s nod
Merck & Co’s combination drug, Keytruda, which treats advanced lung cancer, has been approved by the US drug regulator, the Food and Drug.
Drugs
Health
Pharma
Protein discovery in animal studies holds hope for surgery-free cataract
Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and.
Drugs
Health
Pharma
Organon & Co to buy Riovant’s arm Dermavant Sciences for $1.2 billion
US-based pharmaceutical company Organon & Co., will acquire Riovant Sciences Ltd’s arm — Dermavant Sciences Ltd., specialising in immuno-dermatology — for $1.2 billion.
Drugs
Health
Pharma
AstraZeneca’s rare disease drug Fasenra gets US regulator’s nod
The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.
Drugs
Health
Pharma
Antimicrobial resistance may kill 39.1 million people by 2050: GRAM
Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.